Freeze-Dried CS/PVP/PVA Composite Scaffolds Doped with Curcumin and SiO2 Nanoparticles for Tissue Regeneration
Abstract
In this study, three formulations (F1, F2, and F3) were developed to fabricate hybrid scaffolds composed of chitosan (CS), polyvinylpyrrolidone (PVP), and polyvinyl alcohol (PVA), doped with curcumin (CUR) and silicon dioxide nanoparticles (NPs-SiO2). Structural analysis of the scaffolds was performed using Fourier transform infrared spectroscopy (FTIR), X-ray diffraction (XRD), thermogravimetric analysis (TGA), and scanning electron microscopy (SEM). This analysis demonstrated that incorporating bioactive molecules, such as curcumin (CUR) and silicon dioxide nanoparticles (NPs-SiO2), modified intermolecular interactions within the prepared scaffolds, thereby favoring the formation of more stable amorphous structures. This effect was most evident in scaffold formulation 3, which exhibited a more porous architecture with a uniform distribution of NPs-SiO2. Furthermore, mechanical evaluation of the formulations revealed that F2 exhibited the highest elastic modulus (0.773 ± 0.177 MPa) and compressive strength (1.015 ± 0.012 MPa), while F3 showed a more balanced combination of flexibility, structural stability, and displacement capacity. All formulations achieved complete inhibition of the Gram-positive and Gram-negative bacterial strains evaluated under the same test conditions. In vitro studies demonstrated that F3 maintained cell viability above 80% in normal BHK-21 fibroblasts while exhibiting enhanced cytotoxicity toward HEp-2 tumor cells (IC50 = 373.6 µg/mL).…
Read the paper
Related studies
- The Matrisome: In Silico Definition and In Vivo Characterization by Proteomics of Normal and Tumor Extracellular Matrices
- The Escherichia coli MG1655 in silico metabolic genotype: Its definition, characteristics, and capabilities
- In silico pharmacology for drug discovery: methods for virtual ligand screening and profiling
- In silico prediction of splice-altering single nucleotide variants in the human genome
- In silico clinical trials: how computer simulation will transform the biomedical industry
- In silico optimization of a guava antimicrobial peptide enables combinatorial exploration for peptide design
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.